In a new research report, a team of scientists led by Johns Hopkins Medicine say people with severe obesity and a common type of heart failure experience weakened heart muscles, and that losing weight may reverse some of ...
Apr 23, 2026
0
8
Among adults with both obesity and an autoimmune disease, those taking a glucagon-like peptide-receptor 1 agonist (GLP-1RA) medication had lower rates of emergency department visits and were less likely to experience serious ...
Jun 6, 2026
0
8
A new daily pill to help with weight loss has been approved by the U.S. Food and Drug Administration (FDA), and it moved through review faster than most drugs in recent years.
Apr 2, 2026
0
8
Drinking alcohol may lead people to overconsume savory ultra-processed foods, according to new research from the University of Sydney's Charles Perkins Centre, with researchers suggesting this may contribute to excess energy ...
Jun 3, 2026
0
8
A meta-analysis of 32 studies and 43,618 adults presented at the European Congress on Obesity in Istanbul, Turkey (May 12–15) shows that use of new classes of obesity drugs for weight loss is associated with a clinically ...
May 15, 2026
0
8
Over the last three decades, differences in unhealthy cholesterol levels and blood pressure between older adults with obesity and those with a normal body mass index (BMI) have narrowed or disappeared in several high-income ...
Jul 1, 2026
0
8
In people with type 2 diabetes, semaglutide was associated with a 15% reduction in bone fractures and greater weight loss compared with other anti-obesity medications, according to a study presented at ENDO 2026, the Endocrine ...
Jun 14, 2026
0
8
Researchers surveyed 114 sports medicine physicians from 38 countries, covering 93 different sports, to explore their views on athletes' use of GLP-1 drugs. Twelve percent said they were aware of athletes using the medications ...
Aug 20, 2026
0
8
The American Heart Association and the American College of Cardiology, along with two other leading medical organizations, have developed the first-ever guideline aimed at preventing and managing cardiovascular-kidney-metabolic ...
Jun 9, 2026
0
8
New research presented at the European Congress on Obesity (ECO 2026, Istanbul, Turkey, 12–15 May) shows that, following treatment for obesity or diabetes or both, using incretin-based drugs, losing more weight versus less ...
May 9, 2026
0
8
